Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Moleculin Biotech, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q1 2023
- Shares held
- 2.29M
- −740.9K (−24.5%) vs. Q1 2023
- Total value
- $1.33M
- −$1.58M (−54.4%) vs. Q1 2023
- New holders
- 3
- 4 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,080,122 | $625.2K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 303,389 | $175.6K | 0.06% | −707,567−70.0% | Reduced |
| Geode Capital Management, LLC | 246,451 | $142.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 196,196 | $113.6K | 0.00% | −62,496−24.2% | Reduced |
| Renaissance Technologies LLC | 127,400 | $74.0K | 0.00% | +32,795+34.7% | Added |
| Squarepoint Ops LLC | 77,238 | $44.7K | 0.00% | +53,298+222.6% | Added |
| State Street Corp | 71,397 | $41.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 53,596 | $31.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 33,741 | $19.5K | 0.00% | +33,741 | New |
| Schmidt P J Investment Management Inc | 29,000 | $19.0K | 0.00% | +29,000 | New |
| Sigma Planning Corp | 17,000 | $9.84K | 0.00% | −40,500−70.4% | Reduced |
| Tower Research Capital LLC (TRC) | 14,374 | $8.32K | 0.00% | +2,045+16.6% | Added |
| Jmac Enterprises LLC | 13,132 | $7.60K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,115 | $7.59K | 0.00% | −406−3.0% | Reduced |
| Morgan Stanley | 6,334 | $3.67K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 977 | $1.00K | 0.00% | +977 | New |
| Advisor Group Holdings, Inc. | 968 | $560 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 500 | $289 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 250 | $145 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 214 | $124 | 0.00% | +16+8.1% | Added |
| Bank of America Corp | 100 | $58 | 0.00% | −6,650−98.5% | Reduced |
| FMR LLC | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −31,926−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,534−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −15,635−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,101−100.0% | Sold out |